US FDA approves Acer Therapeutics’ genetic disorder drug
The approval letter, issued recently, said the drug, sodium phenylbutyrate, could be used as an adjunctive therapy to the standard…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.